Back to homepage

Endocrinology

Can bone turnover markers help to define the suitability and duration of bisphosphonate drug holidays?

Authors: Louise Statham MPharm, PGClin Dip, PGCHE, IPresc, Sharon Abdy RN, BSc (Hons), Terry J Aspray MBBS, MD, FRCP, FRCP(Edinburgh)

The aim of this study was to analyse changes in C-terminal telopeptide on stopping long-term blood pressures in a real-world population to see whether
persistence of BP effect was maintained.

More

Management of type 2 diabetes: consensus of diabetes organizations

Authors: Elaena Quattrocchi BS, PharmD, FASHP, CDE, Tamara Goldberg BS, PharmD, BCPS, Nino Marzella BS, MS, PharmD

This article reviews the recommendations of different diabetes organizations for achieving glycemic control.

More

Thyrotoxicosis after massive triiodothyronine (LT3) overdose: a coast-to-coast case series and review

Authors: Zhiheng H He MD, PhD, Yan Li MD, Nitin Trivedi MD, Sabrina Gill MD, James V Hennessey MD

Excessive exogenous thyroid hormone ingestion may lead to severe thyrotoxicosis and cause potential harm; this review of the literature suggests that thyroid hormone supplementation should not be used to alleviate nonspecific complaints in patients with normal endogenous thyroid function.

More

Clinical potential of treatment with semaglutide in type 2 diabetes patients

Authors: Michael E Røder

This review discusses the efficacy and safety of semaglutide, which have
been investigated in an extensive clinical development
program including more than 9,000 patients with type 2
diabetes.

More

Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options

Authors: Rudolf Hoermann, John E M Midgley, Rolf Larisch, Johannes W Dietrich

This review discusses levothyroxine therapy in the alleviation of hypothyroidism, focusing on complex needs, the available options and setpoints.

More